I have been fortunate to have been centrally involved in five Royal College of Anaesthetists (RCoA) National Audit Projects learning from major complications of anaesthesia: as clinical lead for NAP3 and 4 (NAP3 – epidurals/spinal anaesthesia, NAP4 – airway management) and as co-lead and director of the program for NAP5-7 (NAP5 – accidental awareness during general anaesthesia – undoubtedly the most ‘patient facing’ of all NAPs to date – NAP6 – perioperative anaphylaxis and NAP7- perioperative cardiac arrest which will launch in May 2021). These big projects involve the nation’s anaesthetists collaborating to shine a light on patient-centred aspects of anaesthetic practice and safety. They are a form of professional-citizen science and are recognised to have changed the landscape of UK anaesthesia clinical practice and anaesthesia research engagement.
Like many colleagues I have an overall interest in improving safety and quality in anaesthesia and intensive care using a bottom up approach.
During the COVID-19 pandemic I spent several months working from home, during which time I kept my ear to the ground and sought to aid organisational preparedness. Since July I’ve been back to anaesthesia and since October 2020 back full time to ICM. During this time my research interests have been the differential impact of COVID-19 on healthcare staff, aerosol science and clinician safety, survival from ICU and airway management.
I have been honoured to be awarded the RCoA Macintosh Professorship 2012-13, the Difficult Airway Society Professorship 2014, an honorary Professorship in Bristol University in 2016.